LPAA
Launch One Acquisition Corp.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Launch One Acquisition Corp.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Largest filed tie
0
filed ties
—
No changes.
No changes.
We are a blank check company incorporated on February 21, 2024 as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We may pursue an initial business combination in any business or industry but expect to focus on a target in industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare related industries and, in particular, life sciences, globally. We intend to prioritize companies in the life sciences sector where our management team has extensive experience. Experienced SPAC Management Team with Business Combination Success. Joining our company is a team of high-level senior life sciences executives. The team includes Ryan Gilbert, who will serve as our Chairman of the Board upon the commencement of trading of our units on Nasdaq, Chris Ehrlich, our Chief Executive Officer, and Jurgen van de Vyver, our Chief Financial Officer. Our Board of Directors is expected to provide valuable guidance, technical domain expertise, value-added input regarding senior team leadership capabilities of prospective business combination targets, and have access to differentiated ideas and opportunities through complementary networks. They also have specific special purpose acquisition company, or SPAC, experience and a proven track record of business combination success. Our executive offices are located at 180 Grand Avenue, Suite 1530, Oakland CA.
We are a blank check company incorporated on February 21, 2024 as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We may pursue an initial business combination in any business or industry but expect to focus on a target in industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare related industries and, in particular, life sciences, globally. We intend to prioritize companies in the life sciences sector where our management team has extensive experience. Experienced SPAC Management Team with Business Combination Success. Joining our company is a team of high-level senior life sciences executives. The team includes Ryan Gilbert, who will serve as our Chairman of the Board upon the commencement of trading of our units on Nasdaq, Chris Ehrlich, our Chief Executive Officer, and Jurgen van de Vyver, our Chief Financial Officer. Our Board of Directors is expected to provide valuable guidance, technical domain expertise, value-added input regarding senior team leadership capabilities of prospective business combination targets, and have access to differentiated ideas and opportunities through complementary networks. They also have specific special purpose acquisition company, or SPAC, experience and a proven track record of business combination success. Our executive offices are located at 180 Grand Avenue, Suite 1530, Oakland CA.
Annual filing, covered
10-K parsed · Mar 27 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Mar 27 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
—
Same SIC code · 6
Same SEC industry code: Innventure, Inc., Artius II Acquisition Inc., Armada Acquisition Corp. III and 3 more; no measured co-movers for Launch One Acquisition Corp..
Same SIC code · 6
Same SEC industry code: Innventure, Inc., Artius II Acquisition Inc., Armada Acquisition Corp. III and 3 more; no measured co-movers for Launch One Acquisition Corp..
Launch One Acquisition Corp.
10.70
−0.18 · −1.65%
post 10.87 +1.59%
Expected move
No implied move.
| Manager | Value | % base | |
|---|---|---|---|
| Vivaldi | $22.4M | 9.64% | 0.00% |
| LMR Partners | $21.5M | 9.22% | 0.00% |
| Magnetar Financial | $21.1M | 9.07% | 0.00% |
| W. R. Berkley | $18.2M | 7.81% | +12.64% |
| Picton Mahoney | $18.1M | 7.77% | 0.00% |
| Manager | Value | % base | |
|---|---|---|---|
| Vivaldi | $22.4M | 9.64% | 0.00% |
| LMR Partners | $21.5M | 9.22% | 0.00% |
| Magnetar Financial | $21.1M | 9.07% | 0.00% |
| W. R. Berkley | $18.2M | 7.81% | +12.64% |
| Picton Mahoney | $18.1M | 7.77% | 0.00% |